JNJ: Analysis & Opinions

  1. Lilly to Go Solo with LY2605541 - Analyst Blog

    January 11, 2013
    Eli Lilly and Company (LLY) recently announced that it will be developing diabetes candidate, LY2605541, on its own. ...
  2. Covidien Closes CV Ingenuity Buyout - Analyst Blog

    January 11, 2013
    Large-cap medical technologies company, Covidien plc. (COV) has successfully completed the acquisition of Fremont, ...
  3. Shire to Buy Lotus Tissue Repair - Analyst Blog

    January 10, 2013
    Shire plc (SHPG) recently announced its intention to acquire privately-held biotech company, Lotus Tissue Repair, ...
  4. Digital Realty Expands in Australia - Analyst Blog

    January 10, 2013
    In order to expand its Australian footprints, Digital Realty Trust Inc. (DLR) recently acquired an established data ...
  5. Alkermes Maintains Fiscal 2013 View - Analyst Blog

    January 09, 2013
    Alkermes plc (ALKS) recently reaffirmed its view for fiscal 2013 (ending March 31, 2013). The company continues to ...
  6. Sanofi Acquires Rolaids Rights - Analyst Blog

    January 08, 2013
    Sanofi's (SNY) US consumer healthcare division, Chattem, Inc., recently announced that it has acquired worldwide ...
  7. J&J's TB Drug Approved - Analyst Blog

    January 03, 2013
    Johnson & Johnson's (JNJ) Janssen Therapeutics recently announced that it gained FDA approval for its tuberculosis ...
  8. FDA Approves Covidien Drug - Analyst Blog

    January 02, 2013
    Mallinckrodt, the Pharmaceuticals business of Covidien plc (COV), has won the U.S. Food and Drug Administration ...
  9. US Approval for Eliquis - Analyst Blog

    December 31, 2012
    Recently, Bristol-Myers Squibb Company (BMY) and partner Pfizer Inc. (PFE) received some encouraging news when the ...
  10. Covidien Remains at Neutral - Analyst Blog

    December 28, 2012
    We have reiterated our Neutral recommendation on leading health care products maker, Covidien plc. (COV), with a ...
  11. Covidien to Acquire CV Ingenuity - Analyst Blog

    December 27, 2012
    Large-cap medical technologies company, Covidien plc. (COV) has entered into a definitive agreement to acquire ...
  12. SNN Closes Healthpoint Acquisition - Analyst Blog

    December 27, 2012
    As expected, international medical device major, Smith & Nephew plc (SNN) recently completed the acquisition of ...
  13. Back to Neutral on Bayer - Analyst Blog

    December 26, 2012
    We are reverting to a Neutral recommendation on Bayer (BAYRY) as we believe that all the positive news that led to ...
  14. Cooper Downgraded to Neutral - Analyst Blog

    December 26, 2012
    We downgrade our recommendation on The Cooper Companies (COO) to Neutral following its fiscal fourth quarter (ended ...
  15. SNN Extends Legion Knee System - Analyst Blog

    December 26, 2012
    Orthopedic major Smith & Nephew (SNN) recently extended its well-regarded Legion Total Knee System with Legion ...
  16. COV Presents Positive Study Results - Analyst Blog

    December 21, 2012
    Covidien plc. (COV), a large-cap healthcare products company, has announced the five-year results of the ClosureFAST ...
  17. Myriad Alleviates to Outperform - Analyst Blog

    December 21, 2012
    Following a strong first quarter result and an encouraging guidance, we upgrade our recommendation on Myriad ...
  18. Encouraging News for Shire - Analyst Blog

    December 21, 2012
    Shire plc (SHPG) recently received some encouraging news from Europe regarding its attention deficit/hyperactivity ...
  19. NVO Progresses with Pipeline - Analyst Blog

    December 20, 2012
    Novo Nordisk (NVO) recently completed a phase IIIa study on IDegLira, which is a combination of Tresiba (insulin ...
  20. Stock Market News for December 20, 2012 - Market News

    December 20, 2012
    Talks between Democrats and Republicans on the Fiscal Cliff issue took a negative turn, dragging the benchmarks into ...
Marketplace
Trading Center